2020
DOI: 10.3389/fsurg.2020.599392
|View full text |Cite
|
Sign up to set email alerts
|

Case Report: Response to Intra-arterial Cisplatin and Concurrent Radiotherapy Followed by Salvage Surgery in a Patient With Advanced Primary Sinonasal Low-Grade Non-intestinal Adenocarcinoma

Abstract: Background: The clinical usefulness of concurrent chemoradiotherapy before surgery in the treatment of primary, locally advanced sinonasal low-grade, non-intestinal type adenocarcinoma (LG non-ITAC) is unclear.Methods: We present the first case report of the efficacy of super-selective intra-arterial cisplatin (CDDP) infusion concurrent with conventional fractionated radiotherapy (RT) for LG non-ITAC in a Japanese patient.Results: A white, rugged-marginal mass that was histopathologically diagnosed as LG non-I… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 24 publications
0
4
0
Order By: Relevance
“…LG non-ITAC is very rare, and the report by Tachino et al is the only one in the literature on the clinical and therapeutic characteristics of LG non-ITAC in Japan. 1 Consequently, this is the second reported case ( Table 1 ). LG non-ITAC is observed in a wide range of age groups and primarily develops in the nasal cavity or paranasal sinuses, such as the ethmoidal and maxillary sinuses.…”
Section: Discussionmentioning
confidence: 75%
See 3 more Smart Citations
“…LG non-ITAC is very rare, and the report by Tachino et al is the only one in the literature on the clinical and therapeutic characteristics of LG non-ITAC in Japan. 1 Consequently, this is the second reported case ( Table 1 ). LG non-ITAC is observed in a wide range of age groups and primarily develops in the nasal cavity or paranasal sinuses, such as the ethmoidal and maxillary sinuses.…”
Section: Discussionmentioning
confidence: 75%
“…At present, however, there is no established pharmacotherapy for LG non-ITAC. 1 The 5-year survival rate of LG non-ITAC is good at !80%. On the other hand, HG non-ITAC is characterized by rapid tumor progression, and the 3-year survival rate is approximately 20%.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations